Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew E Place

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 23, 2002
A novel dicyanotriterpenoid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide productionTadashi Honda, Yukiko Honda, Frank G Favaloro, et al.
Journal of Clinical Pathology|June 24, 2026
Paediatric B-lymphoblastic leukaemia with low peripheral blasts: a potential diagnostic pitfallEmily M Harris, Matthew M Heeney, Andrew E Place, et al.
Pediatric Blood & Cancer|December 12, 2018
A single institutional review of pediatric Bacillus spp. bloodstream infections demonstrates increased incidence among children with cancerDavid S Shulman, Preeti Mehrotra, Traci M Blonquist, et al.
Journal of Cancer|May 22, 2023
Venetoclax Penetrates the Blood Brain Barrier: A Pharmacokinetic Analysis in Pediatric Leukemia PatientsMohamed Badawi, Rajeev Menon, Andrew E Place, et al.
Frontiers in Pediatrics|January 28, 2026
Outcomes of T-cell lymphoblastic lymphoma in children and adolescents treated with Dana-Farber Cancer Institute Childhood ALL Consortium protocolsGiacomo Gotti, Yael Flamand, Victoria Koch, et al.
Clinical Case Reports|November 29, 2023
Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantationFranziska Wachter, Yana Pikman, Jacob Bledsoe, et al.
Blood Advances|October 5, 2021
Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium TrialsYannis K Valtis, Kristen E Stevenson, Andrew E Place, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivoAndrew E Place, Nanjoo Suh, Charlotte R Williams, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Altered immune and treatment response gene expression signatures among poverty-exposed children with B-ALLAmy Guillaumet-Adkins, Noori Sotudeh, Sayalee Potdar, et al.
Leukemia|January 4, 2024
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium ProtocolsYannis K Valtis, Yael Flamand, Shai Shimony, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|March 23, 2002
A novel dicyanotriterpenoid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide productionTadashi Honda, Yukiko Honda, Frank G Favaloro, et al.
Journal of Clinical Pathology|June 24, 2026
Paediatric B-lymphoblastic leukaemia with low peripheral blasts: a potential diagnostic pitfallEmily M Harris, Matthew M Heeney, Andrew E Place, et al.
Pediatric Blood & Cancer|December 12, 2018
A single institutional review of pediatric Bacillus spp. bloodstream infections demonstrates increased incidence among children with cancerDavid S Shulman, Preeti Mehrotra, Traci M Blonquist, et al.
Journal of Cancer|May 22, 2023
Venetoclax Penetrates the Blood Brain Barrier: A Pharmacokinetic Analysis in Pediatric Leukemia PatientsMohamed Badawi, Rajeev Menon, Andrew E Place, et al.
Frontiers in Pediatrics|January 28, 2026
Outcomes of T-cell lymphoblastic lymphoma in children and adolescents treated with Dana-Farber Cancer Institute Childhood ALL Consortium protocolsGiacomo Gotti, Yael Flamand, Victoria Koch, et al.
Clinical Case Reports|November 29, 2023
Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantationFranziska Wachter, Yana Pikman, Jacob Bledsoe, et al.
Blood Advances|October 5, 2021
Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium TrialsYannis K Valtis, Kristen E Stevenson, Andrew E Place, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivoAndrew E Place, Nanjoo Suh, Charlotte R Williams, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Altered immune and treatment response gene expression signatures among poverty-exposed children with B-ALLAmy Guillaumet-Adkins, Noori Sotudeh, Sayalee Potdar, et al.
Leukemia|January 4, 2024
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium ProtocolsYannis K Valtis, Yael Flamand, Shai Shimony, et al.
Pageof 6